We are very pleased to announce the publication of the first article describing our Quantum Blue® Infliximab trough level assay. The authors around Professor F. Magro claim that: “On the basis of this study, we may conclude that the point-of-care Quantum Blue is a reliable alternative to the time-consuming ELISAs, allowing the fast and accurate assessment of
Social Links